Molecular Oncology Research Center (Barretos Cancer Hospital)
General information
Assertion criteria
Level: Assertion criteria provided
Summary of submissions to ClinVar
Total submissions: 109
Gene
| Gene | Submissions | Last Updated |
|---|---|---|
| A1CF | 1 | Oct 20, 2020 |
| ABCB1 | 1 | Oct 20, 2020 |
| ABCG2 | 1 | Oct 20, 2020 |
| ACACA | 1 | Oct 20, 2020 |
| AIM2 | 1 | Oct 20, 2020 |
| ATM | 2 | Oct 20, 2020 |
| BCAR1 | 1 | Oct 20, 2020 |
| BCL2L1 | 1 | Oct 20, 2020 |
| BIRC6 | 1 | Oct 20, 2020 |
| C11orf65 | 1 | Oct 20, 2020 |
| CCNG1 | 1 | Oct 20, 2020 |
| CDK20 | 1 | Oct 20, 2020 |
| CHD1L | 1 | Oct 20, 2020 |
| CHEK2 | 3 | Jan 25, 2024 |
| COL2A1 | 1 | Oct 20, 2020 |
| CSMD3 | 1 | Oct 20, 2020 |
| CTNNA1 | 1 | Oct 20, 2020 |
| CTNNA2 | 1 | Oct 20, 2020 |
| DMBT1 | 1 | Oct 20, 2020 |
| DROSHA | 1 | Oct 20, 2020 |
| EED | 1 | Oct 20, 2020 |
| EGFR | 1 | Oct 20, 2020 |
| ENO2 | 1 | Oct 20, 2020 |
| EP300 | 1 | Oct 20, 2020 |
| ERCC6 | 1 | Oct 20, 2020 |
| ERCC8 | 1 | Oct 20, 2020 |
| ESCO2 | 1 | Oct 20, 2020 |
| EXO1 | 1 | Oct 20, 2020 |
| EYA2 | 1 | Oct 20, 2020 |
| FAN1 | 2 | Oct 20, 2020 |
| FANCE | 1 | Oct 20, 2020 |
| FEN1 | 1 | Oct 20, 2020 |
| FLCN | 1 | Oct 20, 2020 |
| FLNA | 1 | Oct 20, 2020 |
| FOXD1 | 1 | Oct 20, 2020 |
| GPHN | 1 | Oct 20, 2020 |
| HERPUD1 | 1 | Oct 20, 2020 |
| ID3 | 1 | Oct 20, 2020 |
| INSL6 | 1 | Oct 20, 2020 |
| JAK2 | 1 | Oct 20, 2020 |
| KIT | 1 | Oct 20, 2020 |
| KRAS | 1 | Oct 20, 2020 |
| KRT19 | 1 | Oct 20, 2020 |
| LASP1 | 1 | Oct 20, 2020 |
| LCP1 | 1 | Oct 20, 2020 |
| LEPROTL1 | 1 | Oct 20, 2020 |
| LIFR | 1 | Oct 20, 2020 |
| LOC101928847 | 1 | Oct 20, 2020 |
| LOC107988030 | 1 | Oct 20, 2020 |
| LOC126806995 | 1 | Oct 20, 2020 |
| LOC126807401 | 1 | Oct 20, 2020 |
| LOC126862741 | 1 | Oct 20, 2020 |
| LOC130007287 | 1 | Oct 20, 2020 |
| LRP12 | 1 | Oct 20, 2020 |
| MAFG | 1 | Oct 20, 2020 |
| MED28 | 1 | Oct 20, 2020 |
| MELK | 1 | Oct 20, 2020 |
| MITF | 1 | Oct 20, 2020 |
| MLH1 | 1 | Jan 25, 2024 |
| MME | 1 | Oct 20, 2020 |
| MRE11 | 1 | Oct 20, 2020 |
| MSH2 | 1 | Oct 20, 2020 |
| MSH6 | 1 | Oct 20, 2020 |
| MTMR10 | 1 | Oct 20, 2020 |
| MUTYH | 1 | Oct 20, 2020 |
| MYO5A | 1 | Oct 20, 2020 |
| NBPF3 | 1 | Oct 20, 2020 |
| NCAM1 | 1 | Oct 20, 2020 |
| NEK3 | 1 | Oct 20, 2020 |
| NEMF | 1 | Oct 20, 2020 |
| NFKB2 | 1 | Oct 20, 2020 |
| NOTCH2 | 1 | Oct 20, 2020 |
| PAK4 | 1 | Oct 20, 2020 |
| PAX7 | 1 | Oct 20, 2020 |
| PCSK7 | 1 | Oct 20, 2020 |
| PDGFB | 1 | Oct 20, 2020 |
| PLCG1 | 1 | Oct 20, 2020 |
| PLK2 | 1 | Oct 20, 2020 |
| PMS1 | 1 | Oct 20, 2020 |
| PMS2 | 1 | Oct 20, 2020 |
| POLQ | 1 | Oct 20, 2020 |
| PTCH1 | 1 | Oct 20, 2020 |
| PTPRK | 1 | Oct 20, 2020 |
| PUM1 | 1 | Oct 20, 2020 |
| RAD51C | 1 | Oct 20, 2020 |
| RAD54L | 2 | Oct 20, 2020 |
| RALGDS | 1 | Oct 20, 2020 |
| RECQL | 1 | Oct 20, 2020 |
| RFC1 | 1 | Oct 20, 2020 |
| RIPK1 | 1 | Oct 20, 2020 |
| RPN1 | 1 | Oct 20, 2020 |
| SAV1 | 1 | Oct 20, 2020 |
| SLC34A2 | 1 | Oct 20, 2020 |
| SMAD7 | 1 | Oct 20, 2020 |
| SP100 | 1 | Oct 20, 2020 |
| TACC3 | 1 | Oct 20, 2020 |
| TDG | 1 | Oct 20, 2020 |
| TERT | 1 | Oct 20, 2020 |
| TES | 1 | Oct 20, 2020 |
| TFRC | 1 | Oct 20, 2020 |
| TG | 1 | Oct 20, 2020 |
| TLX3 | 1 | Oct 20, 2020 |
| TNC | 1 | Oct 20, 2020 |
| TPM4 | 1 | Oct 20, 2020 |
| TSHR | 1 | Oct 20, 2020 |
| TYRO3 | 1 | Oct 20, 2020 |
| UFL1 | 1 | Oct 20, 2020 |
| UNG | 1 | Oct 20, 2020 |
| VRK1 | 1 | Oct 20, 2020 |
| VTI1A | 1 | Oct 20, 2020 |
| WDR11 | 1 | Oct 20, 2020 |
| WIF1 | 1 | Oct 20, 2020 |
| WWOX | 1 | Oct 20, 2020 |
Condition
| Name | Submissions | Last Updated |
|---|---|---|
| Hereditary breast ovarian cancer syndrome | 109 | Jan 25, 2024 |